- Design
- Population-based surveillance cohort, time-dependent exposure analysis
- Population
- 6,044 children <18 years admitted with laboratory-confirmed influenza, 2014–2023
- Primary outcome
- Time from symptom onset to ICU admission
- Effect
- Adjusted HR 0.69 (95% CI 0.60 to 0.80); discharge HR 1.13 (1.06 to 1.21)
FluSurv-NET, a population-based US surveillance network across 13 states, provided nine influenza seasons of data on children under 18 admitted with laboratory-confirmed influenza. The analysis of ICU admission included 6,044 children, 70% of whom received oseltamivir; the median age was three and half had a chronic condition, most often asthma.
Treating oseltamivir as a time-dependent exposure — so that children were counted as treated only from the moment they received it — oseltamivir was associated with a lower hazard of ICU admission (adjusted HR 0.69, 95% CI 0.60 to 0.80) and quicker discharge (HR for discharge 1.13, 1.06 to 1.21).
Use of antivirals in admitted children has been falling, partly because of doubts about trial evidence. This is observational and cannot rule out every confounder, but its design addresses a common bias in earlier studies, and it supports current advice to start oseltamivir promptly in any child admitted with suspected or confirmed influenza, without waiting for test results.
- Start oseltamivir promptly in any child admitted with suspected or confirmed influenza
- Do not wait for a test result before treating an admitted child in influenza season
- Treat even if symptoms began more than 48 hours ago in a child sick enough to be admitted
- Prioritise children with asthma and other chronic conditions, who made up half of admissions
- Adjust the dose for age, weight and kidney function
Why it matters
Antiviral use in admitted children has been falling, and this suggests that costs some children an ICU bed.
Don't overread it
This was observational; residual confounding could account for part of the association.
The statistics, in plain English
A hazard ratio of 0.69 means treated children were admitted to ICU at about 31% lower rate at any given time. Counting treatment only from when it started avoids crediting the drug for time before it was given, a common error in older studies.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free